226 related articles for article (PubMed ID: 36815703)
1. Strategy toward Kinase-Selective Drug Discovery.
Zhang M; Liu Y; Jang H; Nussinov R
J Chem Theory Comput; 2023 Mar; 19(5):1615-1628. PubMed ID: 36815703
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors.
Panicker RC; Chattopadhaya S; Coyne AG; Srinivasan R
Adv Exp Med Biol; 2019; 1163():253-278. PubMed ID: 31707707
[TBL] [Abstract][Full Text] [Related]
3. Exploration and Comparison of the Geometrical and Physicochemical Properties of an αC Allosteric Pocket in the Structural Kinome.
Sturm N; Tinivella A; Rastelli G
J Chem Inf Model; 2018 May; 58(5):1094-1103. PubMed ID: 29697977
[TBL] [Abstract][Full Text] [Related]
4. KinomeRun: An interactive utility for kinome target screening and interaction fingerprint analysis towards holistic visualization on kinome tree.
Ansar S; Vetrivel U
Chem Biol Drug Des; 2020 Oct; 96(4):1162-1175. PubMed ID: 32418310
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis of kinase inhibitor selectivity using structural knowledge.
Lo YC; Liu T; Morrissey KM; Kakiuchi-Kiyota S; Johnson AR; Broccatelli F; Zhong Y; Joshi A; Altman RB
Bioinformatics; 2019 Jan; 35(2):235-242. PubMed ID: 29985971
[TBL] [Abstract][Full Text] [Related]
6. KinScan: AI-based rapid profiling of activity across the kinome.
Brahma R; Shin JM; Cho KH
Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37985454
[TBL] [Abstract][Full Text] [Related]
7. KiSSim: Predicting Off-Targets from Structural Similarities in the Kinome.
Sydow D; Aßmann E; Kooistra AJ; Rippmann F; Volkamer A
J Chem Inf Model; 2022 May; 62(10):2600-2616. PubMed ID: 35536589
[TBL] [Abstract][Full Text] [Related]
8. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
Verkhivker GM
Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
[TBL] [Abstract][Full Text] [Related]
9. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
[TBL] [Abstract][Full Text] [Related]
10. Novel method to identify group-specific non-catalytic pockets of human kinome for drug design.
Wang H; Guan Z; Qiu J; Jia Y; Zeng C; Zhao Y
RSC Adv; 2020 Jan; 10(4):2004-2015. PubMed ID: 35494619
[TBL] [Abstract][Full Text] [Related]
11. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity virtual profiling of the human kinome by X-react(KIN): a chemical systems biology approach.
Brylinski M; Skolnick J
Mol Pharm; 2010 Dec; 7(6):2324-33. PubMed ID: 20958088
[TBL] [Abstract][Full Text] [Related]
13. Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay.
Wang W; Mevellec L; Liu A; Struble G; Miller R; Allen SJ; Federowicz K; Wroblowski B; Vialard J; Ahn K; Krosky D
Biochemistry; 2021 Oct; 60(41):3114-3124. PubMed ID: 34608799
[TBL] [Abstract][Full Text] [Related]
14. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
Verkhivker GM
Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
[TBL] [Abstract][Full Text] [Related]
15. Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket.
Forster M; Chaikuad A; Bauer SM; Holstein J; Robers MB; Corona CR; Gehringer M; Pfaffenrot E; Ghoreschi K; Knapp S; Laufer SA
Cell Chem Biol; 2016 Nov; 23(11):1335-1340. PubMed ID: 27840070
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features.
Fang Z; Grütter C; Rauh D
ACS Chem Biol; 2013 Jan; 8(1):58-70. PubMed ID: 23249378
[TBL] [Abstract][Full Text] [Related]
17. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of human protein kinase Aurora A linked to drug selectivity.
Pitsawong W; Buosi V; Otten R; Agafonov RV; Zorba A; Kern N; Kutter S; Kern G; Pádua RA; Meniche X; Kern D
Elife; 2018 Jun; 7():. PubMed ID: 29901437
[TBL] [Abstract][Full Text] [Related]
19. αC helix displacement as a general approach for allosteric modulation of protein kinases.
Palmieri L; Rastelli G
Drug Discov Today; 2013 Apr; 18(7-8):407-14. PubMed ID: 23195331
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
Verkhivker GM
Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
